Search by Drug Name or NDC

    NDC 27854-0505-02 Flanax Pain Reliever/Fever reducer 220 mg/1 Details

    Flanax Pain Reliever/Fever reducer 220 mg/1

    Flanax Pain Reliever/Fever reducer is a ORAL TABLET, COATED in the HUMAN OTC DRUG category. It is labeled and distributed by Belmora LLC. The primary component is NAPROXEN SODIUM.

    Product Information

    NDC 27854-0505
    Product ID 27854-505_937b99a5-63ed-4f0d-8866-69c60d9743d8
    Associated GPIs
    GCN Sequence Number n/a
    GCN Sequence Number Description n/a
    HIC3 n/a
    HIC3 Description n/a
    GCN n/a
    HICL Sequence Number n/a
    HICL Sequence Number Description n/a
    Brand/Generic n/a
    Proprietary Name Flanax Pain Reliever/Fever reducer
    Proprietary Name Suffix n/a
    Non-Proprietary Name Naproxen Sodium
    Product Type HUMAN OTC DRUG
    Dosage Form TABLET, COATED
    Route ORAL
    Active Ingredient Strength 220
    Active Ingredient Units mg/1
    Substance Name NAPROXEN SODIUM
    Labeler Name Belmora LLC
    Pharmaceutical Class Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA090545
    Listing Certified Through 2024-12-31

    Package

    NDC 27854-0505-02 (27854050502)

    NDC Package Code 27854-505-02
    Billing NDC 27854050502
    Package 1 BOTTLE in 1 CARTON (27854-505-02) / 2 TABLET, COATED in 1 BOTTLE
    Marketing Start Date 2020-05-15
    NDC Exclude Flag N
    Pricing Information N/A

    Standard Product Labeling (SPL)/Prescribing Information SPL 05337e0b-8baf-42d6-a642-3052f77ed304 Details

    Revised: 5/2020